Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus.

Somerset, D A; Raine-Fenning, N; Gordon, C; Weaver, J B; Kilby, M D

Somerset, D A; Raine-Fenning, N; Gordon, C; Weaver, J B; Kilby, M D.

Affiliation

Somerset DA; Department of Materno-Fetal Medicine, Birmingham Women's Hospital, Edgbaston, UK. d.a.somerset@bham.ac.uk

Eur J Obstet Gynecol Reprod Biol ; 79(2): 227-9, 1998 Aug.

Article in En | MEDLINE | ID: mdl-9720848

Subject(s)

Antiphospholipid Syndrome/therapy; Immunoglobulins, Intravenous/therapeutic use; Lupus Erythematosus, Systemic/therapy; Pregnancy Complications/therapy; Adult; Female; Humans; Pregnancy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications / Immunoglobulins, Intravenous / Antiphospholipid Syndrome / Lupus Erythematosus, Systemic Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 1998 Document type: Article

Search on Google

XML

PubMed Links